The relationship between adenosine triphosphate within CD4+ T lymphocytes and acute rejection after liver transplantation

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages

  Dong, Jia Yong ^a   Yin, Hao ^a   Li, Rui Dong ^a   Ding, Guo Shan ^a   Fu, Zhi Ren ^a   Wu, You Min ^b   Wang, Zheng Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acute rejection (AR); Adenosine triphosphate (ATP); CD4+ T lymphocyte; Liver transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOCORTICOID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE FUNCTION TEST; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL PARAMETERS; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REJECTION ACTING INDEX; SENSITIVITY AND SPECIFICITY;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 79958728244     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01429.x     Document Type: Article

References (16)

1. Volpin R, Angeli P, Galioto A et al. Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial. Liver Transpl 2002: 8: 527.
2. Andreu H, Rimola A, Bruguera M et al. Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy. Transplantation 2002: 73: 1936.
3. Tippner C, Nashan B, Hoshino K et al. Clinical and subclinical acute rejection early after liver transplantation: contributing factors and relevance for the long-term course. Transplantation 2001: 72: 1122.
4. Israeli M, Klein T, Sredni B et al. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl 2008: 14: 893.
5. Israeli M, Yussim A, Mor E, Sredni B, Klein T. Preceding the rejection: in search for a comprehensive post-transplant immune monitoring platform. Transpl Immunol 2007: 18: 7.
6. Bhorade SM, Janata K, Vigneswaran WT, Alex CG, Garrity ER. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant 2008: 27: 990.
7. Demetris AJ, Batts KP, Dhillon AP. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997: 25: 658.
8. Venkataramanan R, Shaw LM, Sarkozi L et al. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol 2001: 41: 542.
9. Rovira P, Mascarell L, Truffa-Bachi P. The impact of immunosuppressive drugs on the analysis of T cell activation. Curr Med Chem 2000: 7: 673.
10. Gautam A, Fischer SA, Yango AF et al. Cell mediated immunity (CMI) and post transplant viral infections - role of a functional immune assay to titrate immune-suppression. Int Immunopharmacol 2006: 6: 20230.
11. Sampson VB, Dunn SP, Rymeski B et al. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. J Pediatr Surg 2008: 43: 1134.
12. Kowalski RJ, Post DR, Mannon RB et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 2006: 82: 663.
13. Hooper E, Hawkins DM, Kowalski RJ et al. Establishing pediatric immune response zones using the Cylex ImmuKnowTM assay. Clin Transplant 2005: 19: 834.
14. Cabrera R, Ararat M, Soldevila-Pico C et al. Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients. Liver Transpl 2009: 15: 216.
15. Kowalski R, Post D, Schneider MC et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 2003: 17: 77.
16. Xue F, Zhang J, Han L et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection [J]. Transplantation, 2010: 89: 620.